Objective To investigate the cellular immunity status of glioma patients and their correlation with the WHO classification of gliomas. Methods The clinical data of 92 patients with newly diagnosed patients analyzed retrospectively.Preoperative cellular immunity was measured by flow cytometry and WHO classification of gliomas were confirmed by postoperative pathology. The correlation between cellular immunity and WHO classification of glioma was analyzed by Spearman's rank correlation coefficient. Results No statistically significant differences were observed concerning CD3⁺,CD4⁺,CD8⁺,CD4⁺/CD8⁺,CD16⁺CD56⁺orCD19⁺(P<0.05).No significant correlation between cellular immunity and WHO classification of gliomas were observed by Spearman's rank correlation coefficient(P<0.05). Conclusions There is no significant correlation between patient's cellular immunity and WHO classification of gliomas. Preoperative cellular immunity test can not differentiate low grade glioma from high grade glioma.

 

 

 

Glioma, Cellular immunity, WHO classification